Y-Intercept (HK)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,664
Closed -$571K 1656
2026
Q1
$571K Buy
+25,664
New +$613K 0.01% 1229
2025
Q4
Sell
-111,273
Closed -$2.37M 1486
2025
Q3
$2.37M Buy
+111,273
New +$2.63M 0.06% 512
2025
Q2
Sell
-14,527
Closed -$241K 1593
2025
Q1
$241K Sell
14,527
-18,378
-56% -$334K 0.02% 983
2024
Q4
$604K Sell
32,905
-17,639
-35% -$285K 0.04% 638
2024
Q3
$777K Sell
50,544
-39,245
-44% -$655K 0.05% 554
2024
Q2
$1.46M Sell
89,789
-51,647
-37% -$834K 0.08% 347
2024
Q1
$2.62M Buy
+141,436
New +$3.5M 0.2% 115
2023
Q4
Sell
-68,887
Closed -$1.44M 1178
2023
Q3
$1.44M Buy
68,887
+48,928
+245% +$1.33M 0.14% 216
2023
Q2
$478K Sell
19,959
-8,190
-29% -$182K 0.05% 578
2023
Q1
$530K Buy
28,149
+4,286
+18% +$81.6K 0.06% 497
2022
Q4
$380K Sell
23,863
-5,278
-18% -$82.5K 0.06% 546
2022
Q3
$477K Buy
29,141
+15,071
+107% +$244K 0.05% 556
2022
Q2
$198K Buy
14,070
+4,169
+42% +$77.8K 0.03% 686
2022
Q1
$240K Sell
9,901
-98
-1% -$2.37K 0.05% 538
2021
Q4
$233K Buy
+9,999
New +$201K 0.06% 470

Other funds holding ACAD